Establishing secure connection…Loading editor…Preparing document…

Latisse Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!
Latisse Consent Form

What the Latisse Consent Form Is and Why It’s Used

The Latisse Consent Form documents a patient’s informed consent to receive bimatoprost ophthalmic solution (Latisse) for eyelash hypotrichosis or cosmetic eyelash enhancement. It explains intended use, expected benefits, common and rare side effects, application instructions, contraindications, and follow-up expectations. The form records medical history, allergies, pregnancy or breastfeeding status, and agreement to photograph or document treatment progress when required. It also captures patient and prescriber signatures and dates to demonstrate consent and meet clinical, regulatory, and insurance documentation needs.

Why a Proper Consent Form Matters for Latisse

A clear, signed consent protects patient safety and documents that the patient received risk disclosures and application instructions. Clinicians reduce legal and regulatory exposure when consent records contain required medical, pregnancy, and allergy information and a dated signature confirming understanding.

Why a Proper Consent Form Matters for Latisse

Who Should Complete the Latisse Consent Form

The form is completed by the patient or a legally authorized representative before first application; a licensed prescriber must review and sign.

  • Adult patients receiving Latisse or a licensed prescriber confirming suitability and dosage instructions.
  • Parents or legal guardians when the patient is a minor and local law allows parental authorization.
  • Clinic administrators retaining the signed form in the patient record for compliance and audit purposes.

Ensure signatures are dated and any delegate (guardian or agent) identification is recorded to avoid disputes about consent validity.

Essential Sections to Include in a Professional Consent Form

A comprehensive Latisse consent form groups clinical facts, risks, instructions, signatory details, and release language so clinicians and patients have the same expectations.

Patient Details

Full legal name, date of birth, address, and contact details to match medical records and avoid identification errors during follow-up.

Medical History

Relevant ocular history, glaucoma status, current ocular medications, allergy list, and note of any active eye infection or dermatologic conditions.

Risks and Side Effects

Clear description of common effects (irritation, redness) and rarer outcomes (iris pigmentation change, eyelid darkening, lash loss) with expected incidence and monitoring steps.

Application Instructions

Precise directions for nightly topical application, recommended dose, when to discontinue, and how to avoid contact with eye surface to reduce adverse events.

Consent and Releases

Affirmation of informed consent, photo release for treatment records if used, and acknowledgement of receipt of written instructions.

Signatures

Signature lines for patient and prescriber with printed names, credentials, dates, and space for guardian signature when applicable.

Step-by-Step: Filling Out and Signing the Latisse Consent

Follow these steps to complete the form correctly and ensure the consent is valid for clinical use and recordkeeping.

  • 01
    Review Information: Read risks, benefits, and instructions before answering fields.
  • 02
    Complete Medical Fields: Enter allergies, ocular history, and current medications accurately.
  • 03
    Confirm Pregnancy Status: Indicate pregnancy/breastfeeding status to guide prescribing decisions.
  • 04
    Sign and Date: Patient and prescriber sign; include guardian if required.

Customizing the Form for Online Completion and eSignature

Configure online fields, authentication, and conditional logic so the digital consent captures the same data as a paper form.

Field and configuration mapping table How to set each field for online completion with validation and help text
Patient full legal name field Make required; enable autofill and validation against ID or patient record
Date fields (MM/DD/YYYY format) Use date picker and enforce MM/DD/YYYY to ensure consistent records
Consent checkbox and initial fields Set required and use conditional logic to show photo release options
Provider signature field settings Require signer authentication and attach signer role as 'Prescriber'

Where to Send or Store the Completed Consent Form

Decide a single authoritative destination for the signed document to ensure traceability and clinical access.

  • Electronic Health Record: Upload signed PDF to the patient’s EHR chart for care continuity.
  • Clinic Records Folder: Store a copy in the clinic’s secure records directory for internal audits.
  • Patient Copy: Provide patient a secure digital copy or printed copy on request.
  • Third-Party Archive: Use HIPAA-compliant cloud storage when permitted by policy.

Digital Signing and Technical Requirements

Choose an eSignature platform that supports secure authentication and HIPAA controls for patient health information.

  • Authentication: Email or SMS code
  • Security: TLS and AES-256
  • HIPAA: BAA required

Timelines and Recommended Follow-Up for Latisse Treatment

Track key dates: consent effective date, recommended follow-up intervals, and documentation retention start points.

Consent effective date:

Date of patient signature; treatment may proceed thereafter per clinic policy.

Initial follow-up visit:

Typically scheduled 4–6 weeks after start to assess response and side effects.

Photo documentation period:

Retain treatment photos per clinic policy and any stated release terms.

Prescription validity:

Follow state prescription validity rules; check state-specific limits before renewal.

Revocation or update:

Patient may revoke consent in writing; record date and clinical response steps.

Common Mistakes to Avoid When Preparing the Form

  • Failing to record pregnancy or breastfeeding status, which can lead to inappropriate prescribing decisions and increased liability.
  • Leaving medical history or current ocular medication fields incomplete, obscuring contraindications to bimatoprost use.
  • Not obtaining a dated patient signature or guardian authorization when required, risking consent disputes.
  • Using unclear photo release language that does not specify permitted uses or duration of image retention.

Consequences of an Incorrect or Missing Consent

Clinical Risk: Adverse events or improper treatment
Malpractice Claim: Increased legal exposure
Regulatory Action: State medical board review
Insurance Denial: Claim or coverage refusal
HIPAA Violation: Unauthorized PHI disclosure
Documentation Gaps: Lost patient trust and audit findings

Real-World Use Cases for a Latisse Consent Form

These examples show how clinics and providers document consent and follow-up in routine aesthetic and medical workflows.

Private Ophthalmology Clinic

The patient received a verbal explanation and written consent form before first application

  • Clinic photographed baseline eyelids
  • Signed consent retained in EHR and used to track efficacy and adverse events over six months.

Medical Spa Workflow

A licensed prescriber reviewed medical history remotely and approved prescription via telemedicine

  • Patient completed the consent electronically with authentication
  • The spa stored the signed PDF in a HIPAA-compliant archive and scheduled a four-week check-in.

Frequently Asked Questions About the Latisse Consent Form

Answers to common questions about validity, e-signatures, minors, pregnancy, and how to correct or revoke consent.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users